Journal article · 2011 · Open access
Pharmacotherapy for treatment-resistant schizophrenia
Neuropsychiatric Disease and Treatment, 7, 135 · Published 1 March 2011 · DOI 10.2147/ndt.s12769
In brief
“Pharmacotherapy for treatment-resistant schizophrenia” is a 2011 journal article by Jeff Harrison and 3 co-authors, published in Neuropsychiatric Disease and Treatment. OpenAlex counts 72 citations as of 20 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Neuropsychiatric Disease and Treatment.
- Citations
- 72
- Most cited in
- 2015 (10)
- Field-weighted impact
- 5.39
- References
- 108
- Authors
- 4
Abstract
Schizophrenia is a disabling mental illness with a lifetime prevalence of 0.7% worldwide and significant, often devastating, consequences on social and occupational functioning. A range of antipsychotic medications are available; however, suboptimal therapeutic response in terms of psychotic symptoms is common and affects up to one-third of people with schizophrenia. Negative symptoms are generally less amenable to treatment. Because of the consequences of inadequate symptom control, effective treatment strategies are required for people with treatment-resistant schizophrenia. Clozapine has been shown to be more effective than other antipsychotics in treatment-resistant populations in several studies; however, the occurrence of adverse effects, some of which are potentially life-threatening, are important limitations. In addition to those who are intolerant to clozapine, only 30% to 50% experience clinically significant symptom improvement. This review describes the recent evidence for treatment strategies for people not responding to nonclozapine antipsychotic agents and people not responding or only partially responding to clozapine.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Harrison, J., McIlwain, M., Wheeler, A., & Russell. (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease and Treatment, 7, 135. https://doi.org/10.2147/ndt.s12769
MLA 9
Harrison, Jeff, et al. “Pharmacotherapy for treatment-resistant schizophrenia.” Neuropsychiatric Disease and Treatment, vol. 7, 2011, p. 135. https://doi.org/10.2147/ndt.s12769.
Chicago
Harrison, Jeff, Meghan McIlwain, Amanda Wheeler, and Russell. 2011. “Pharmacotherapy for treatment-resistant schizophrenia.” Neuropsychiatric Disease and Treatment 7: 135. https://doi.org/10.2147/ndt.s12769.
Harvard
Harrison, J. et al. (2011) ‘Pharmacotherapy for treatment-resistant schizophrenia’, Neuropsychiatric Disease and Treatment, 7, p. 135. doi:10.2147/ndt.s12769.
IEEE
J. Harrison, M. McIlwain, A. Wheeler, and Russell, “Pharmacotherapy for treatment-resistant schizophrenia,” Neuropsychiatric Disease and Treatment, vol. 7, p. 135, 2011, doi: 10.2147/ndt.s12769.
BibTeX
@article{harrison2011pharmacotherapy,
title = {{Pharmacotherapy for treatment-resistant schizophrenia}},
author = {Harrison, Jeff and McIlwain, Meghan and Wheeler, Amanda and Russell},
journal = {Neuropsychiatric Disease and Treatment},
year = {2011},
volume = {7},
pages = {135},
doi = {10.2147/ndt.s12769},
url = {https://doi.org/10.2147/ndt.s12769}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 10 | |
| 2016 | 4 | |
| 2017 | 2 | |
| 2018 | 6 | |
| 2019 | 8 | |
| 2020 | 2 | |
| 2021 | 5 | |
| 2022 | 1 | |
| 2024 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 5.39: it has been cited 5.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- treatment-resistant schizophrenia
- clozapine
- antipsychotic drugs
- negative symptoms
- pharmacotherapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Harrison, J., McIlwain, M., Wheeler, A., & Russell. (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease and Treatment, 7, 135. https://doi.org/10.2147/ndt.s12769
How many times has this paper been cited?
72 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Neuropsychiatric Disease and Treatment: sign in and open the PDF from this page.
Who wrote this paper?
Jeff Harrison, Meghan McIlwain, Amanda Wheeler, Russell.
What is the DOI of this paper?
10.2147/ndt.s12769, permanently at https://doi.org/10.2147/ndt.s12769. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.